language-icon Old Web
English
Sign In

Dalotuzumab

Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.'-mexi-' (melanoma): Ecromeximab§ Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers. Dalotuzumab was developed by Merck & Co., Inc.

[ "Protein kinase B", "PI3K/AKT/mTOR pathway", "Insulin-like growth factor 1 receptor", "Colorectal cancer", "Breast cancer" ]
Parent Topic
Child Topic
    No Parent Topic